bexarotene has been researched along with Tauopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhungana, H; Goldsteins, G; Huuskonen, MT; Kanninen, KM; Keksa-Goldsteine, V; Koistinaho, J; Koponen, J; Korhonen, P; Landreth, G; Lemarchant, S; Loppi, S; Malm, T; Pollari, E; Takashima, A; Valonen, P; Wojciechowski, S | 1 |
1 other study(ies) available for bexarotene and Tauopathies
| Article | Year |
|---|---|
Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy.
Topics: Aging; Animals; Autophagy; Bexarotene; Mice; Mice, Transgenic; Neuroprotective Agents; Stroke; Tauopathies; Tetrahydronaphthalenes; Thromboembolism | 2016 |